Prognostic and predictive value of ALDH1, SOX2 and SSEA-4 in bladder cancer

por Matias Blomqvist, Ilmari Koskinen, Eliisa Löyttyniemi, Tuomas Mirtti, Peter J. Boström, Pekka Taimen
Publicado 2021

Immunological tumor status may predict response to neoadjuvant chemotherapy and outcome after radical cystectomy in bladder cancer

por Minna Tervahartiala, Pekka Taimen, Tuomas Mirtti, Ilmari Koskinen, Thorsten Ecke, Sirpa Jalkanen, Peter J. Boström
Publicado 2017

High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer.

por Paula Vainio, John-Patrick Mpindi, Pekka Kohonen, Vidal Fey, Tuomas Mirtti, Kalle A Alanen, Merja Perälä, Olli Kallioniemi, Kristiina Iljin
Publicado 2012